Acquired rifampicin resistance in thrice-weekly antituberculosis therapy: impact of HIV and antiretroviral therapy.

G. Narendran , P. A. Menon , P. Venkatesan , K. Vijay
Clinical Infectious Diseases 59 ( 12) 1798 -1804

23
2014
Efficacy and Safety of Once-Daily Nevirapine- or Efavirenz-Based Antiretroviral Therapy in HIV-Associated Tuberculosis: A Randomized Clinical Trial

Soumya Swaminathan Soumya Swaminathan , Chandrasekaran Padmapriyadarsini Chandrasekaran Padmapriyadarsini , Perumal Venkatesan Perumal Venkatesan , Gopalan Narendran Gopalan Narendran
Clinical Infectious Diseases 53 ( 7) 716 -724

56
2011
CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India.

Geetha Ramachandran , AK Hemanth Kumar , Sikhamani Rajasekaran , P Kumar
Antimicrobial Agents and Chemotherapy 53 ( 3) 863 -868

60
2009
Immune reconstitution inflammatory syndrome in HIV-infected patients with and without prior tuberculosis:

S Ramesh Kumar , Narendran Gopalan , Paru Patrawalla , Pradeep Menon
International Journal of Std & Aids 23 ( 6) 419 -423

10
2012
Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study

Akshay N Gupte , Pavan Kumar , Mariana Araújo-Pereira , Vandana Kulkarni
European Respiratory Journal 59 ( 4)

4
2022
Treatment of W. bancrofti (Wb) in HIV/Wb coinfections in South India

Kawsar R Talaat , Subash Babu , Pradeep Menon , N Kumarasamy
PLoS Negl Trop Dis 9 ( 3) e0003622 -e0003622

6
2015
Increasing trend of HIV seroprevalence among pulmonary tuberculosis patients in Pune, India.

Mehendale Sm , Khatavkar P , Gadkari Da , Paranjape Rs
Indian Journal of Medical Research 106 207 -211

45
1997
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

A Ericsen , M Lauck , M Mohns , S Dinapoli
Journal of the International AIDS Society 19 ( 6 Suppl 5) 21264 -21264

3
2016